NDC 63323-481-01 - Xylocaine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-481
- Requested NDC
- 63323-481-01
- Package NDCs from labels
- 63323-481-01, 63323-481-57
- Manufacturer
- Henry Schein, Inc
- Effective date
- 2025-08-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Xylocaine - Henry Schein, Inc | Henry Schein, Inc | 2025-08-07 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine - General Injectables & Vaccines, Inc | General Injectables & Vaccines, Inc | 2022-12-22 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine MPF - Fresenius Kabi USA, LLC | Fresenius Kabi Austria | Fresenius Kabi USA, LLC | Fresenius Kabi Austria | 2021-08-25 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-481-01 | Xylocaine | 50 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 50 | 13 | |
| 63323-481-57 | Xylocaine | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 13 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63323-481 | XYLOCAINE MPF (LIDOCAINE HYDROCHLORIDE) INJECTION, SOLUTION XYLOCAINE (LIDOCAINE HYDROCHLORIDE) INJECTION, SOLUTION XYLOCAINE MPF (LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 13 | Current NDC, Legacy NDC, 2 package rows | 20210831_ba082c2f-64f4-419d-9c88-74f203316e17.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63323-481-57 | ML - Milliliter | 63323-481 | 27e8b3c9-2007-4f4b-ba9e-56cc304eebbf | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| LIDOCAINE HCI | LIDOCAINE HCI | HF Acquisition Co LLC, DBA HealthFirst | c901016e-9293-79dd-e053-2a95a90a0fda | 2024-01-27 | Warnings, Adverse reactions | 1737761 |
| LIDOCAINE HCl | LIDOCAINE HCL | HF Acquisition Co LLC, DBA HealthFirst | e39435a3-1f69-78c5-e053-2995a90a7fc3 | 2024-01-27 | Warnings, Adverse reactions | 1737568 |
| 0.5% LIDOCAINE HCl | 0.5% LIDOCAINE HCL | HF Acquisition Co LLC, DBA HealthFirst | e52fe254-8872-35ce-e053-2a95a90a339e | 2024-01-27 | Warnings, Adverse reactions | 1737343 |
| 0.9% SODIUM CHLORIDE | 0.9% SODIUM CHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | e5247ed5-6170-c13f-e053-2a95a90a4101 | 2024-01-27 | Warnings, Adverse reactions | 451W47IQ8X |
| XYLOCAINE- MPF (LIDOCAINE HCl ) | LIDOCAINE HCL | HF Acquisition Co LLC, DBA HealthFirst | e8b987c8-b5cb-74cd-e053-2a95a90a5a93 | 2024-01-27 | Warnings, Adverse reactions | NDA006488 1737761 1737762 EC2CNF7XFP |
| BSS | BALANCED SALT SOLUTION | Alcon Laboratories, Inc. | 4bd4d59c-eb3b-4a5e-9eb7-ae95b0a92bea | 2024-01-25 | Warnings, Adverse reactions | 451W47IQ8X |
| CIRCULATION HP | ARNICA MONTANA, AURUM METALLICUM, CACTUS GRANDIFLORUS, CALCAREA CARBONICA, LACHESIS MUTUS, NATRUM MURIATICUM, NUX VOMICA, PHOSPHORUS, SOLIDAGO VIRGAUREA, | Energique, Inc. | 464d208b-3893-4ec6-9868-12ef6807b98d | 2024-01-23 | Warnings | 451W47IQ8X |
| DERMA SCALE HP | ARSENICUM IODATUM, BORAX, GRAPHITES, LYCOPODIUM CLAVATUM, NATRUM MURIATICUM, PETROLEUM, SEPIA, SULPHUR | Energique, Inc. | 64961787-7e9a-4e6f-98ce-0f51934155cf | 2024-01-23 | Warnings | 451W47IQ8X |
| XYLOCAINE(R) -MPF (LIDOCAINE HCI AND EPINEPHRINE) | XYLOCAINE(R) -MPF (LIDOCAINE HCI AND EPINEPHRINE) | HF Acquisition Co LLC, DBA HealthFirst | 971439ed-4507-7a30-e053-2a95a90a1f1c | 2024-01-22 | Warnings, Adverse reactions | NDA006488 1867943 30Q7KI53AK EC2CNF7XFP |
| LIDOCAINE HCI AND EPINEPHRINE WITH EPINEPHRINE | LIDOCAINE HCI AND EPINEPHRINE WITH EPINEPHRINE | HF Acquisition Co LLC, DBA HealthFirst | 94e9f2db-af29-032e-e053-2995a90a7f7b | 2024-01-22 | Warnings, Adverse reactions | NDA006488 1868028 30Q7KI53AK EC2CNF7XFP |
| LIDOCAINE HCI | LIDOCAINE HCI | HF Acquisition Co LLC, DBA HealthFirst | 995e68a7-6986-423e-e053-2995a90acd98 | 2024-01-22 | Warnings, Adverse reactions | 1737761 1737566 |
| XYLOCAINE | XYLOCAINE | HF Acquisition Co LLC, DBA HealthFirst | 0c6c5678-e987-b822-e063-6394a90ac88b | 2024-01-22 | Warnings, Adverse reactions | NDA006488 1010033 EC2CNF7XFP |
| Energy Complex | ECHINACEA (ANGUSTIFOLIA), LAPPA MAJOR, SOLIDAGO VIRGAUREA, TARAXACUM OFFICINALE, ADRENALINUM, ALOE, ARSENICUM ALBUM, BAPTISIA TINCTORIA, BERBERIS AQUIFOLIUM, BERBERIS VULGARIS, BRYONIA (ALBA), CHELIDONIUM MAJUS, CROTALUS HORRIDUS, DIGITALIS PURPUREA, FERRUM METALLICUM, GLONOINUM, GLYCYRRHIZA GLABRA, HYDROCOTYLE ASIATICA, IODIUM, IRIS VERSICOLOR, LACHESIS MUTUS, LYCOPODIUM CLAVATUM, NATRUM MURIATICUM, NUX VOMICA, RHUS TOX, RUTA GRAVEOLENS, THUJA OCCIDENTALIS, THYROIDINUM (BOVINE) | Health Masters LLC | 9286ca29-8190-4867-9231-b0d68180cb10 | 2024-01-22 | Warnings | 451W47IQ8X |
| Pain Relief | LIDOCAINE, MENTHOL | HUMN Pharmaceuticals Inc | 6c96f94a-e724-eab3-e053-2991aa0aab88 | 2024-01-17 | Warnings | EC2CNF7XFP |
| Sodium Chloride | SODIUM CHLORIDE | Spectra Medical Deviecs, LLC | 7e316d21-d6ad-4976-bd90-268fd7e51361 | 2024-01-12 | Adverse reactions | 451W47IQ8X |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE ANHYDROUS | Spectra Medical Devices, LLC | e8ba012a-08a9-4f67-9f88-3284377e80be | 2024-01-12 | Warnings, Adverse reactions | 1737566 EC2CNF7XFP |
| A01 CELLULAR RECHARGE | ACETICUM ACIDUM, ARNICA MONTANA, AVENA SATIVA, CALCAREA CARBONICA, CALCAREA PHOSPHORICA, CALCAREA SULPHURICA, CEANOTHUS AMERICANUS, CERATOSTIGMA ILLMOTTIANUM, CHININUM ARSENICOSUM, CITRICUM ACIDUM, ENGLISH ELM, EUROPEAN HORNBEAM, EUROPEAN OLIVE, GENTIANELLA AMARELLA, HYDROFLUORICUM ACIDUM, JUGLANS REGIA, LACTICUM ACIDUM, MAGNESIA PHOSPHORICA, NATRUM MURIATICUM, NATRUM PHOSPHORICUM, NATRUM SILICOFLUORICUM, NATRUM SULPHURICUM, PASSIFLORA INCARNATA, PHOSPHORICUM ACIDUM, SARCOLACTICUM ACIDUM, SOLIDAGO VIRGAUREA | Apex Energetics Inc. | b932ebd3-afea-6a95-e053-2995a90a2735 | 2024-01-08 | Warnings | 451W47IQ8X |
| A12 DTX-KIDNEY | APIS MELLIFICA, BERBERIS VULGARIS, BETULA PUBESCENS BARK, BETULA VERRUCOSA LEAF, BOS TAURUS KIDNEY, BOS TAURUS URINARY BLADDER, CITRICUM ACIDUM, CITRUS LIMONUM, FAGUS SYLVESTRIS FLOWER BUD, NATRUM MURIATICUM, PETROSELINUM SATIVUM, QUERCUS ROBUR FLOWER BUD, SINUSITISINUM, SOLIDAGO VIRGAUREA | Apex Energetics Inc. | bf52e26f-aa27-87ca-e053-2995a90a23e7 | 2024-01-08 | Warnings | 451W47IQ8X |
| B07 DPRSN ANTITOX | ADRENALINUM, AETHUSA CYNAPIUM, AGNUS CASTUS, ALFALFA, ARGENTUM NITRICUM, AURUM METALLICUM, AVENA SATIVA, CERATOSTIGMA WILLMOTTIANUM FLOWER, CHERRY PLUM FLOWER, DAMIANA, EUROPEAN ASPEN FLOWER, EUROPEAN HORNBEAM FLOWER, GORSE FLOWER, HYPERICUM PERFORATUM, KALI PHOSPHORICUM, LYCOPODIUM CLAVATUM, MANDRAGORA OFFICINARUM, NATRUM MURIATICUM, PASSIFLORA INCARNATA, ROSA CANINA FLOWER, SEPIA, SWEET CHESTNUT FLOWER, THYROIDINUM, WILD MUSTARD FLOWER | Apex Energetics Inc. | bd1fbb76-4f6f-7098-e053-2a95a90ae25c | 2024-01-08 | Warnings | 451W47IQ8X |
| B13 CELL SALT COMPLEX | ALLIUM SATIVUM, AVENA SATIVA, CALCAREA CARBONICA, CALCAREA FLUORICA, CALCAREA PHOSPHORICA, CALCAREA SULPHURICA, CARBO VEGETABILIS, FERRUM IODATUM, HYPERICUM PERFORATUM, KALI PHOSPHORICUM, LACTICUM ACIDUM, MAGNESIA PHOSPHORICA, NATRUM MURIATICUM, NATRUM PHOSPHORICUM, PHOSPHORICUM ACIDUM, URTICA URENS | Apex Energetics Inc. | bf78b0b0-5b7b-28cb-e053-2a95a90a1e7d | 2024-01-08 | Warnings | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.